Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.105 AUD | 0.00% | -4.55% | -4.55% |
Business Summary
Number of employees: 5
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rohan Hockings
CEO | Chief Executive Officer | 40 | - |
Andrew Taylor
DFI | Director of Finance/CFO | - | - |
Kevin Hart
DFI | Director of Finance/CFO | 62 | 17-07-23 |
Paula Cunningham
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sue Fletcher
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Sri Mudumba
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 21-03-16 | |
Jason Haddock
BRD | Director/Board Member | 54 | 21-03-28 |
Alan W. Tribe
CHM | Chairman | 76 | 18-04-10 |
Rohan Hockings
CEO | Chief Executive Officer | 40 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,732,867,135 | 1,902,013,553 ( 50.95 %) | 0 | 50.95 % |
Company contact information
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.55% | 326M | |
+46.19% | 55.7B | |
-6.14% | 39.57B | |
+40.06% | 39.91B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
-0.35% | 12.12B | |
+24.18% | 12.12B | |
+28.38% | 12.17B |
- Stock Market
- Equities
- PYC Stock
- Company PYC Therapeutics Limited